990x120 beckman

Summit Program

    10:00 AM – Opening Remarks

    10:15 AM – Biology and Efficacy of Synthetic Antigen Receptors that Signal via the TCR
    Jonathan Bramson, PhD

    11:00 AM – Understanding Resistance to Develop Better CAR T Immunotherapies
    Marco Ruella, MD

    11:45 PM – Advancing CAR T Cells for Glioblastoma Treatment: Progress and Challenges
    Christine E. Brown, PhD

    12:30 PM – High Content Functional and Phenotypic Flow Cytometric Analysis of Tumor Infiltrating Lymphocytes: Guidance for Therapy and Improvement of Product Development
    Markus Maeurer, MD, PhD, FRCP (London)

    1:15 PM – Closing Remarks and Thanks
Tuesday, September 22, 2020
 10:00 AM - 1:30 PM, Eastern Standard Time


Jonathan Bramson, PhD
Vice-Dean Research, Faculty of Health Sciences
Professor, Pathology and Molecular Medicine, McMaster University
Canada Research Chair in Translational Cancer Immunology
CSO, Triumvira Immunologics

Marco Ruella, MD
Assistant Professor of Medicine
Scientific Director Lymphoma Program
Center for Cellular Immunotherapies
University of Pennsylvania

Christine E. Brown, PhD
Heritage Provider Network Professor in Immunotherapy
Deputy Director, T-cell Therapeutics Research Laboratory
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope Comprehensive Cancer Center

Markus Maeurer, MD, PhD, FRCP (London)
Head of Immunotherapy/Immunosurgery Program
Champalimaud Foundation, Portugal
I Med Clinical, University of Mainz, Germany

Summit sponsored by


Register Now

Detecting SARS-CoV-2 with qPCR

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.